EMBECTA CORP.

EMBC ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Operating Activities
Net Income $95.4M $78.3M $70.4M $223.6M $414.8M $427.6M
Depreciation & Amortization $40.7M $36.2M $32.6M $31.7M $38.3M $38.3M
Depreciation $38.1M $34.9M $31.5M $31.0M $37.2M $36.5M
Amortization $1.1M $1.1M $1.2M $700.0K $300.0K $300.0K
Stock-Based Compensation $31.6M $26.3M $21.5M $18.7M $12.8M $12.7M
Net Cash from Operating Activities $191.7M $35.7M $67.7M $412.2M $456.3M $498.5M
Investing Activities
Capital Expenditures $9.3M $15.8M $26.5M $23.6M $36.8M $41.9M
Business Acquisitions
Net Cash from Investing Activities $-9.3M $-15.8M $-26.5M $-24.0M $-39.2M $-41.9M
Financing Activities
Dividends Paid $35.0M $34.5M $34.4M $8.6M $0 $0
Stock Repurchases
Net Cash from Financing Activities $-226.7M $-73.4M $-48.7M $-48.0M $-417.1M $-456.6M
Net Change in Cash $-45.6M $-52.3M $-4.4M $330.9M $0 $0
Free Cash Flow $182.4M $19.9M $41.2M $388.6M $419.5M $456.6M